In numerous disease processes where increased oxidative stress was seen, serum PON1 activity decreased, e.g., dementia and Alzheimer’s disease (32, 33), bronchial asthma (34), and coronary heart disease. This evidence concerns the gene PON1 and early-onset autosomal dominant Alzheimer disease.